Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers.

Authors:
Thomas A Mavrakanas
Thomas A Mavrakanas
Geneva University Hospitals
Switzerland

Can J Diabetes 2018 Apr 22;42(2):118-123. Epub 2017 Dec 22.

Division of Nephrology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Electronic address:

Cardiovascular disease is the principal cause of morbidity and mortality in patients with diabetes mellitus. The incidence or progression of kidney disease is also common in these patients. Several clinical trials have established the efficacy of angiotensin receptor blockers for the prevention of adverse cardiovascular and renal outcomes in this population and are summarized in this review article. Head-to-head comparison of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors has shown similar cardioprotective and renoprotective properties of both medication classes. However, angiotensin receptor blockers have an improved safety profile with fewer episodes of cough and angioedema and may be the agent of choice in patients with diabetes and hypertension. Novel therapeutic strategies, such as those that include a mineralocorticoid receptor blocker or a selective sodium-glucose cotransporter type 2 inhibitor, may further protect patients with diabetes from cardiovascular and renal complications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcjd.2017.11.006DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
April 2018
3 Reads

Publication Analysis

Top Keywords

angiotensin receptor
20
receptor blockers
20
patients diabetes
12
cardiovascular renal
8
angiotensin-converting enzyme
8
enzyme inhibitors
8
receptor
6
blockers
5
angiotensin
5
properties medication
4
cardioprotective renoprotective
4
medication classes
4
inhibitors cardioprotective
4
renoprotective properties
4
blockers improved
4
improved safety
4
blockers angiotensin-converting
4
safety profile
4
classes angiotensin
4
summarized review
4

Similar Publications